Zai Lab To Present First Phase 1/1b Data On Atopic Dermatitis Candidate ZL-1503 In Healthy Volunteers On November 13
Share
Why It Matters
Zai Lab will show early safety test results for a new skin medicine on November 13. When a company shares early test results, watch to see if the medicine is safe and working as hoped.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.